Pier Capital LLC Buys 10,594 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Pier Capital LLC boosted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 2.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 400,489 shares of the company’s stock after purchasing an additional 10,594 shares during the period. Pier Capital LLC’s holdings in Privia Health Group were worth $7,830,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PRVA. Intech Investment Management LLC bought a new stake in Privia Health Group during the 3rd quarter valued at $462,000. Charles Schwab Investment Management Inc. increased its stake in shares of Privia Health Group by 6.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company’s stock valued at $19,380,000 after buying an additional 65,152 shares during the period. Dynamic Technology Lab Private Ltd purchased a new position in shares of Privia Health Group during the third quarter valued at $1,206,000. FMR LLC raised its holdings in shares of Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock valued at $330,858,000 after acquiring an additional 271,645 shares in the last quarter. Finally, Quantbot Technologies LP lifted its stake in Privia Health Group by 82.6% in the third quarter. Quantbot Technologies LP now owns 37,375 shares of the company’s stock worth $681,000 after acquiring an additional 16,904 shares during the period. Institutional investors own 94.48% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on PRVA. Piper Sandler raised their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. Needham & Company LLC reissued a “buy” rating and issued a $30.00 price objective on shares of Privia Health Group in a research note on Friday. Macquarie started coverage on Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. JMP Securities set a $29.00 price objective on Privia Health Group in a research note on Friday, February 28th. Finally, JPMorgan Chase & Co. lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Privia Health Group presently has an average rating of “Buy” and a consensus price target of $26.67.

Privia Health Group Trading Up 2.5 %

Shares of Privia Health Group stock opened at $23.92 on Tuesday. The firm’s 50 day simple moving average is $23.71 and its two-hundred day simple moving average is $21.08. The firm has a market capitalization of $2.88 billion, a price-to-earnings ratio of 239.22, a PEG ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.